258 related articles for article (PubMed ID: 31906950)
1. Plasma proteomic analysis of autoimmune hepatitis in an improved AIH mouse model.
Wang H; Yan W; Feng Z; Gao Y; Zhang L; Feng X; Tian D
J Transl Med; 2020 Jan; 18(1):3. PubMed ID: 31906950
[TBL] [Abstract][Full Text] [Related]
2. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
[TBL] [Abstract][Full Text] [Related]
3. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
4. Complementary serum proteomic analysis of autoimmune hepatitis in mice and patients.
Li H; Li G; Zhao X; Wu Y; Ma W; Liu Y; Gong F; Liang S
J Transl Med; 2013 Jun; 11():146. PubMed ID: 23763817
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients.
Wang H; Feng X; Yan W; Tian D
Front Immunol; 2020; 11():575572. PubMed ID: 33117375
[TBL] [Abstract][Full Text] [Related]
6. A novel "humanized mouse" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.
Yuksel M; Wang Y; Tai N; Peng J; Guo J; Beland K; Lapierre P; David C; Alvarez F; Colle I; Yan H; Mieli-Vergani G; Vergani D; Ma Y; Wen L
Hepatology; 2015 Nov; 62(5):1536-50. PubMed ID: 26185095
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of a mouse model of autoimmune hepatitis induced by human CYP2D6].
Chi G; Ma Q; Pei J; Feng Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Aug; 34(8):690-694. PubMed ID: 30384866
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6.
Hintermann E; Ehser J; Bayer M; Pfeilschifter JM; Christen U
J Autoimmun; 2013 Aug; 44():49-60. PubMed ID: 23809878
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model.
Müller P; Messmer M; Bayer M; Pfeilschifter JM; Hintermann E; Christen U
J Autoimmun; 2016 May; 69():51-8. PubMed ID: 26924542
[TBL] [Abstract][Full Text] [Related]
10. The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development.
Hardtke-Wolenski M; Dywicki J; Fischer K; Hapke M; Sievers M; Schlue J; Anderson MS; Taubert R; Noyan F; Manns MP; Jaeckel E
J Autoimmun; 2017 Mar; 78():39-45. PubMed ID: 27974250
[TBL] [Abstract][Full Text] [Related]
11. The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.
Yuksel M; Xiao X; Tai N; Vijay M; Gülden E; Beland K; Lapierre P; Alvarez F; Hu Z; Colle I; Ma Y; Wen L
Clin Exp Immunol; 2016 Nov; 186(2):164-176. PubMed ID: 27414259
[TBL] [Abstract][Full Text] [Related]
12. L-lysine supplementation attenuates experimental autoimmune hepatitis in a chronic murine model.
Lei Y; Chen Y; Wang S; Lin Z; Han P; Tian D; Wang H; Liu M
Exp Anim; 2024 Feb; 73(1):83-92. PubMed ID: 37648521
[TBL] [Abstract][Full Text] [Related]
13. Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis.
Kimura M; Tatsumi KI; Tada H; Izumi Y; Kaneko A; Kato M; Masuzawa M; Ikemoto M; Yabusaki Y; Hidaka Y; Amino N
Clin Chim Acta; 2002 Feb; 316(1-2):155-64. PubMed ID: 11750286
[TBL] [Abstract][Full Text] [Related]
14. Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool.
Tahiri F; Le Naour F; Huguet S; Lai-Kuen R; Samuel D; Johanet C; Saubamea B; Tricottet V; Duclos-Vallee JC; Ballot E
Hepatology; 2008 Mar; 47(3):937-48. PubMed ID: 18306218
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 2D6 as a model antigen.
Christen U; Holdener M; Hintermann E
Dig Dis; 2010; 28(1):80-5. PubMed ID: 20460894
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis.
Yüksel M; Laukens D; Heindryckx F; Van Vlierberghe H; Geerts A; Wong FS; Wen L; Colle I
Int J Exp Pathol; 2014 Oct; 95(5):309-20. PubMed ID: 25112417
[TBL] [Abstract][Full Text] [Related]
17. A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens.
Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
Hepatology; 2004 Apr; 39(4):1066-74. PubMed ID: 15057911
[TBL] [Abstract][Full Text] [Related]
18. Detection of Novel Biomarkers in Pediatric Autoimmune Hepatitis by Proteomic Profiling.
Sîrbe C; Badii M; Crişan TO; Bența G; Grama A; Joosten LAB; Rednic S; Pop TL
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108648
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
Dalekos GN; Zachou K; Liaskos C; Gatselis N
Eur J Intern Med; 2002 Aug; 13(5):293-303. PubMed ID: 12144908
[TBL] [Abstract][Full Text] [Related]
20. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Zierden M; Kühnen E; Odenthal M; Dienes HP
Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]